http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007137774-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7be158719d9bcf096a0e95ba11b7e8ab |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2005-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1878bd8ccc8b0391f2aff4ab1d40bef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6466a6b1b76520ba811350efea2400a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e511c2a3565cded016ebaf3a05c86200 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_381a9fef1b405753d21460d2f45b2637 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6564b34c2e9ba8ac438f7e62aa8424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dcac36f23d68d395df8036f9dff7bb6 |
| publicationDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007137774-A |
| titleOfInvention | Anti-inflammatory agent and endotoxin shock inhibitor |
| abstract | Lipopolysaccharide (LPS) is called endotoxin, and is known to be released from gram-negative bacteria and cause various reactions in the body. It activates complement in the second pathway, resulting in macrophages and other cells. Cytokines and other immunoregulatory substances are released from the body, and excessive cytokines and the like are toxic to the host, resulting in death such as shock, which is a big problem. There is a need for development of technology for suppressing such endotoxin shock. SOLUTION: Galectins 1 and 9, as well as stabilized galectin 9 and galectin 9 inducer exhibit endotoxin shock inhibitory activity and are useful for the control (or suppression) of endotoxin and related biological reaction phenomenon. Therapeutic and / or prophylactic agent for the disease / disease and its treatment and / or prevention method, and the treatment and / or prevention for inflammation and inflammatory disease, particularly bacterial infection, bacteremia, sepsis, septic shock, endotoxin shock, etc. Useful for suppression. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107287274-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012077811-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9528089-B2 |
| priorityDate | 2005-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.